Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316M Buy
2,950,806
+117,585
+4% +$12.9M 1.16% 19
2026
Q1
$296M Buy
2,833,221
+143,634
+5% +$16.9M 1.18% 19
2025
Q4
$336M Buy
2,689,587
+175,928
+7% +$21M 1.31% 17
2025
Q3
$301M Buy
2,513,659
+546,420
+28% +$57.7M 1.22% 17
2025
Q2
$181M Buy
1,967,239
+1,189,271
+153% +$108M 0.78% 34
2025
Q1
$68.3M Buy
777,968
+67,746
+10% +$6.66M 0.33% 78
2024
Q4
$65.7M Buy
710,222
+26,610
+4% +$2.56M 0.32% 82
2024
Q3
$63.3M Buy
683,612
+5,661
+0.8% +$475K 0.32% 82
2024
Q2
$50.8M Buy
677,951
+5,030
+0.7% +$401K 0.28% 84
2024
Q1
$58M Buy
672,921
+6,205
+0.9% +$474K 0.34% 77
2023
Q4
$46.1M Buy
666,716
+4,064
+0.6% +$245K 0.3% 83
2023
Q3
$35.5M Buy
+662,652
New +$37.7M 0.26% 93

Other funds holding CRH

Rathbones Group's CRH Position: Q2 2026 in Review

Rathbones Group increased its CRH (CRH) stake by 4.2% in Q2 2026, buying an estimated $12.9M and bringing the position to 2,950,806 shares worth $316M. The position accounts for 1.16% of the portfolio, ranked #19.

Rathbones Group first reported a position in CRH in Q3 2023 and has held it in 12 quarters since. The position peaked at $336M in Q4 2025. 358 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Rathbones Group held 2,950,806 shares of CRH worth $316M as of Q2 2026.
  • Rathbones Group bought 117,585 CRH shares in Q2 2026, an estimated $12.9M.
  • CRH made up 1.16% of Rathbones Group's portfolio in Q2 2026, its #19 holding.
  • Rathbones Group first reported a position in CRH in Q3 2023 and has held it in 12 quarters since.
  • Rathbones Group's CRH position peaked at $336M in Q4 2025.
  • 358 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.